NEW DELHI: Weight-loss therapy drug Eli Lilly’s Mounjaro has become the top selling brand in the domestic pharma retail market with sales of nearly Rs 100 crore in Oct, indicating the huge popularity of such treatments across India. Mounjaro has overtaken GSK’s widely prescribed antibiotic and long-established market leader, Augmentin, which totalled sales of Rs 80 crore during the month, the latest data from Pharmatrac said. The sales pattern follows Mumbai and Delhi pockets of affluence, where both high purchasing power and a proliferation of weight-loss clinics are fuelling the demand. A similar trend would be visible in other metros, Sheetal Sapale, vice president at Pharmatrac, told TOI.
